Index trend and stocks in action February 18, 2019
Index trend and stocks in action February 18, 2019

Index trend and stocks in action February 18, 2019

Karan Dsij Article rating: 5.0

Going ahead, a positive follow-through above the Friday’s session high of 10,786 can lead to pull-back towards the level of 10,860 as the important 200-day moving average is placed at this level. On the flip side, the zone of 10,620-10,580 would be the key area to watch out for. Stocks in news: Signet Industries, Dr Reddy’s Laboratories, Tech Mahindra, NBCC, Coffee Day Enterprises, TRF and Wipro.

After the hammering last week, indices hope for a recovery
After the hammering last week, indices hope for a recovery

After the hammering last week, indices hope for a recovery

Karan Dsij Article rating: 5.0

The set-up for the Indian stock markets to begin the week is perfect as cues from the global peers are cheerful and bulls cannot hope for a better pitch than today to come out and take on the bears with their horns after the hammering they received last week. The outlook for the day is a flat start at the time of writing, SGX Nifty is trading around 10,799, up by 24 points. 

Stocks approaching Ex-date this week
Stocks approaching Ex-date this week

Stocks approaching Ex-date this week

Gayathri Udyawar Article rating: 5.0

For an avid investor, earnings are what semester exams are for students. Investors are keen to know how the companies that they hold fared during the quarter and whether they have any goodies to offer. Read on to know which stocks will be approaching their ex-date for bonuses and dividends during the week.

Stocks that attracted mutual fund managers in January 2019
Stocks that attracted mutual fund managers in January 2019

Stocks that attracted mutual fund managers in January 2019

Henil Shah Article rating: 5.0

Many of you are interested in knowing what fund managers are buying and selling. So, let’s find out which stocks attracted the fund managers in the month of January 2019.

Bharat Financial: Bollinger band squeeze pick
Bharat Financial: Bollinger band squeeze pick

Bharat Financial: Bollinger band squeeze pick

Vinayak Gangule Article rating: 5.0

Bharat Financial Inclusion gets picked up by our Bollinger Band Squeeze scanner, suggesting that a consolidation breakout is expected in the near-term.

Lupin launches second generic drug this week
Lupin launches second generic drug this week

Lupin launches second generic drug this week

Pratik Shastri Article rating: 5.0

Indian pharma major Lupin updated that it has launched Clobazam Oral Suspension 2.5/mg which has already got the USFDA approval in the US market. 

Alembic Pharma gets approval for moxifloxacin ophthalmic solution
Alembic Pharma gets approval for moxifloxacin ophthalmic solution

Alembic Pharma gets approval for moxifloxacin ophthalmic solution

Pratik Shastri Article rating: 5.0

Alembic Pharmaceuticals announced that it received USFDA approval for Moxifloxacin Ophthalmic Solution one of its Abbreviated New Drug Application (ANDA). With this, the total approval count for the company is at 86 approvals. 

RSS
First26812682268326842686268826892690Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR